Terns Pharmaceuticals (430.F) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.31
-0.28
-0.25
-0.22

Details

Expected EPS
-0.26182580764
Actual EPS
-0.2316002
Surprise EPS
0.03
Surprise Percent
+11.54%

Description

⁨Terns Pharmaceuticals⁩ (⁦430.F⁩) has reported earnings of ⁦-0.2316002⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts